© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
May 12, 2022
Research and discussion about the high cancer rates among Black Americans used to be dominated by genetics and the search for biological differences. Now attention has shifted to the social determinants of health.
April 20, 2022
Patients with cancer who have a poor prognosis may face obstacles in accessing critical pain medications.
March 16, 2022
The American Cancer Society’s 2022 statistical report shows that the 30-year trend is continuing.
February 21, 2022
Dr Al-Hendy discusses the impact UF has on a patient’s life and their typical patient journey through the healthcare system.
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP, provides a comprehensive background on uterine fibroids, explaining everything from clinical burden to symptoms.
February 03, 2022
Biden is reviving the program he headed as vice president with the goal of reducing the cancer mortality rate and improving the experience of patients and their loved ones.
January 25, 2022
The introduction of an electronic tracking system decreased the time from hepatocellular carcinoma (HCC) diagnosis to treatment by more than a month.
January 24, 2022
The global cancer immunotherapy market is set to grow at a compound annual growth rate, or CAGR, of 12.6% to $277.1 billion by 2030.
January 12, 2022
But the future of value-based care in oncology is uncertain with no certain successor to the Oncology Care Model in sight.
December 22, 2021
Patients with a variety of cancers spent much more money out of their own pocket than those in traditional plans. Some may be delaying treatment due to higher costs.